Comments: NY S08991 | 2023-2024 | General Assembly
Bill Title: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.
Spectrum: Bipartisan Bill
Status: (Introduced) 2024-06-03 - PRINT NUMBER 8991A [S08991 Detail]
Text: Latest bill text (Amended) [HTML]
Spectrum: Bipartisan Bill
Status: (Introduced) 2024-06-03 - PRINT NUMBER 8991A [S08991 Detail]
Text: Latest bill text (Amended) [HTML]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2023 New York S08991 at this time. | |||||
